Information
-
Trademark
-
88850346
-
International Classifications
-
Filing Date
March 27, 2020
4 years ago
-
Transaction Date
September 08, 2024
5 months ago
-
Status Date
October 23, 2023
a year ago
-
Published for Opposition Date
July 28, 2020
4 years ago
-
Location Date
March 21, 2023
a year ago
-
Status Code
606
-
Current Location
INTENT TO USE SECTION
Employee Name
CARROLL, DORITT
-
Attorney Docket Number
TM21-0218
Attorney Name
Kumiko Ide
Law Office Assigned Location Code
M70
-
Owners
Mark Drawing Code
4
Mark Identification
ZILBRYSQ
Case File Statements
- GS0051: Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents
- TR0010: The wording ZILBRYSQ has no meaning in a foreign language.
- GS0101: Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
Case File Event Statements
-
3/31/2020 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/1/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
6/18/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/18/2020 - 4 years ago
4 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
6/18/2020 - 4 years ago
5 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
6/18/2020 - 4 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
6/18/2020 - 4 years ago
7 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
6/18/2020 - 4 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/22/2020 - 4 years ago
9 - ASSIGNED TO LIE
Type: ALIE
-
7/8/2020 - 4 years ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/28/2020 - 4 years ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/28/2020 - 4 years ago
11 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
9/1/2020 - 4 years ago
14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
9/1/2020 - 4 years ago
13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
9/1/2020 - 4 years ago
15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
2/22/2021 - 3 years ago
17 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/22/2020 - 4 years ago
16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
2/22/2021 - 3 years ago
18 - SOU EXTENSION 1 FILED
Type: EXT1
-
2/22/2021 - 3 years ago
19 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
2/24/2021 - 3 years ago
20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
8/26/2021 - 3 years ago
22 - SOU EXTENSION 2 FILED
Type: EXT2
-
8/26/2021 - 3 years ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/26/2021 - 3 years ago
23 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
10/25/2021 - 3 years ago
27 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Type: EWAF
-
8/28/2021 - 3 years ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/25/2021 - 3 years ago
25 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
10/25/2021 - 3 years ago
26 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
10/25/2021 - 3 years ago
28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
12/13/2021 - 3 years ago
30 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
12/13/2021 - 3 years ago
32 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Type: EWAF
-
12/13/2021 - 3 years ago
33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
12/13/2021 - 3 years ago
34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
12/13/2021 - 3 years ago
29 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
12/13/2021 - 3 years ago
31 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
8/31/2022 - 2 years ago
39 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
3/4/2022 - 2 years ago
35 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
3/4/2022 - 2 years ago
36 - SOU EXTENSION 3 FILED
Type: EXT3
-
3/4/2022 - 2 years ago
37 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
3/8/2022 - 2 years ago
38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
8/31/2022 - 2 years ago
40 - SOU EXTENSION 4 FILED
Type: EXT4
-
8/31/2022 - 2 years ago
41 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
9/2/2022 - 2 years ago
42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
3/21/2023 - a year ago
46 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
3/8/2023 - a year ago
43 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
3/8/2023 - a year ago
45 - SOU EXTENSION 5 FILED
Type: EXT5
-
3/21/2023 - a year ago
44 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
3/22/2023 - a year ago
47 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/23/2023 - a year ago
49 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
10/23/2023 - a year ago
48 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
